Page 4 - Velox Am News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Velox am. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Velox Am Today - Breaking & Trending Today

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, a growth of 320.8% from the March 31st total of 49,000 shares. Currently, 14.1% of the company’s shares are short sold. Based on an average […] ....

United States , America Corp , Hedge Funds Weigh In On Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Stock Performance , Eloxx Pharmaceuticals Company Profile , Eloxx Pharmaceuticals , Exchange Commission , Eloxx Pharmaceuticals Inc , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Short Interest in Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Increases By 260.3%

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 49,000 shares, an increase of 260.3% from the March 15th total of 13,600 shares. Based on an average daily volume of 239,300 shares, the […] ....

United States , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Inc , Institutional Trading Of Eloxx Pharmaceuticals , America Corp , Eloxx Pharmaceuticals Stock Down , News Ratings For Eloxx Pharmaceuticals Daily , Get Rating , Pharmaceuticals Stock Down , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Up 260.3% in March

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 49,000 shares, a growth of 260.3% from the March 15th total of 13,600 shares. Based on an average daily volume of 239,300 shares, the short-interest ratio is […] ....

United States , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Inc , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Stock Performance , America Corp , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals (NASDAQ:ELOX) Issues Earnings Results, Beats Estimates By $0.05 EPS

Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) released its earnings results on Monday. The company reported ($2.92) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.97) by $0.05, MarketWatch Earnings reports. Eloxx Pharmaceuticals Stock Performance Shares of ELOX traded up $0.11 during midday trading on Wednesday, reaching $3.36. The stock had a trading […] ....

United States , Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Stock Performance , America Corp , Earnings History For Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Inc , Get Rating , Marketwatch Earnings , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals (ELOX) Set to Announce Earnings on Friday

Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) is scheduled to be issuing its quarterly earnings data on Friday, March 31st. Eloxx Pharmaceuticals Price Performance Shares of Eloxx Pharmaceuticals stock traded down $0.12 during trading hours on Thursday, reaching $2.35. The company’s stock had a trading volume of 673 shares, compared to its average volume of 128,304. […] ....

Earnings History For Eloxx Pharmaceuticals , Exchange Commission , Eloxx Pharmaceuticals Inc , Renaissance Technologies , Eloxx Pharmaceuticals Company Profile , Hedge Funds Weigh In On Eloxx Pharmaceuticals , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Price Performance , News Ratings For Eloxx Pharmaceuticals Daily , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,